BostonGene Named “Overall AI-based Analytics Company of the Year” in 2026 AI Breakthrough Awards Program
Ninth Annual Program Recognizes BostonGene’s Multimodal AI Infrastructure for Reducing Risk and Accelerating Oncology Drug Development
BostonGene, leading developer of AI models for tumor and immune biology, today announced that it has been selected as winner of the “Overall AI-based Analytics Company of the Year” award in the 9th annual AI Breakthrough Awards program conducted by AI Breakthrough, a leading market intelligence organization that recognizes the top companies, technologies and products in the global Artificial Intelligence (AI) market today.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260707614322/en/
For nearly a decade, the AI Breakthrough Awards have researched, analyzed and recognized the most important advances in artificial intelligence, and this year's field is the strongest yet. Thousands of nominations from over 20 countries poured in across categories including Agentic AI, Generative AI, Computer Vision, AIOps, Robotics, Natural Language Processing and industry-specific AI applications– underscoring the explosive global growth of AI and its importance as the defining technology of our time.
